Neurocentrx Closes Seed Extension Round with Wellcome Trust Funds
23 Sep 2025 //
BUSINESSWIRE
Neurocentrx Reports Results from Phase 1 of Lead Oral Ketamine Capsule Programme
24 Oct 2023 //
BUSINESSWIRE
Neurocentrx Provides Update on Clinical Progress of Lead Programme, Keticap
12 May 2023 //
BUSINESSWIRE

Market Place
Sourcing Support